ANTHRACYCLINES ROLE IN ADJUVANT TREATMENT OF BREAST CANCER
    ANTHRACYCLINES ROLE IN ADJUVANT TREATMENT OF BREAST CANCER

ANTHRACYCLINES ROLE IN ADJUVANT TREATMENT OF BREAST CANCER

€10.00
Tax included
Quantity
Add to wishlist
In Stock

Anthracyclines are used in the adjuvant treatment of breast cancer for about 25 years. Recently in the light of new data on taxanes and targeted therapies (trastuzumab) that have proven their effectiveness and the emergence of new predictors of sensitivity to anthracyclines, it was asked the following questions:
1. Is it possible to dispense with anthracyclines and taxanes for the benefit of targeted therapies?!
2. Should we prescribe to all patients anthracyclines?!
3. Is there any predictive factors for selecting patients who will benefit most from anthracyclines.
SKU-1109
30 Items
2050-01-01
New

16 other products in the same category:

RÉUSSIR DANS LA DURÉE: LEÇONS SUR L’AVANTAGE
Quick view

SUCCESS IN TIME: LESSONS ON THE EDGE

€10.00
Availability: 30 In Stock

About the book by Danny Miller and Isabelle Le Breton-Miller, Réussir dans la durée. Lessons about the competitive advantage of large family businesses

About the Book of Richard D'Aveni. A., Beating the commodity trap

About the Book of Francis Ginsburg, Ce qui tue le travail

About the Book Béroud Sophie, Jean-Michel Denis, Guillaume Desage, Baptiste Giraud Pélisse and Jerome, La Lutte continue ? Labour disputes in contemporary France

This website uses cookies to ensure you get the best experience on our website